- Europe under pressure from yesterday's AI sector sell-off
- Canadian CPI data in focus
- Airbus cuts full-year earnings forecasts
Overall market situation:
Tuesday's session on European stock markets is marked by declines. The German DAX is currently losing nearly 1.1% on the spot market. At the same time, the French CAC40 is losing 0.75% and the UK FTSE 100 is down 0.25%. By contrast, the leader of the gains in Europe is the Polish WIG20, which is adding 0.35%. Investors are looking with uncertainty at the weakness in the semiconductor sector, which has pushed Nvidia nearly 16% away from historic highs.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Volatility currently seen in the DAX index. Source: Bloomberg Financial LP
Volatility currently observed in the broad European market. Source: xStation
The German benchmark DE40 is down nearly 0.35% during today's session. The index is still in the structure of the downtrend initiated on 16 May. The continuation of the downward trend led to a test of the historically important support level in the zone of the 100-day exponential moving average (purple curve on the chart, it still remains a key support point). Locally, the most important resistance all the time remains the zone of the 50-day exponential moving average (blue curve). The DE40 index is currently testing this zone.
Interestingly, the test of the zones of the previously mentioned 100-day EMA brought a clear activation on the volume side. This may indicate that we have seen a lot of institutional investor activation in this zone. Source: xStation 5
News:
BASF SE (BAS.DE) and Eramet SA (ERA.FR) abandoned plans to spend up to $2.6 billion to build a nickel-cobalt refinery in Indonesia after a slowdown in electric vehicle sales. The global availability of battery-quality nickel has improved since the project's inception, BASF said in a statement on Monday.
Baader Helvea raised its recommendation on shares of Wacker Chemie (WCH.DE) to a 'buy' rating from its previous 'reduce' rating with a target price of €122.
Missing Airbus (AIR.FR) parts are forcing a reduction in targets against accelerating A320 production. The company has also reduced its full-year profit and free cash flow forecasts. The company's shares are losing nearly 12% today.
Suppliers of parts to aircraft manufacturers are trading down on Tuesday following this news. Rolls Royce loses -3.3%, Safran -3.5%, Leonardo -3.8%, Sopra Steria -1.5%, Alten -1.1% and Capgemini -0.3%.
Evotec Biologics, a subsidiary of Evotec (EVT.DE), was selected by the US Department of Defense for its biotherapeutics manufacturing optimisation programme.
Merck KGaA (MRK.DE) shares lose 11% after the German pharmaceutical and chemical company discontinued research into Xevinapant for the treatment of head and neck cancer. Analysts questioned the company's growth prospects in healthcare and its R&D strategy after the incident.
Other news coming out of individual DAX index companies. Source: Bloomberg Financial LP
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
